Emergent BioSolutions (EBS) Leases: 2019-2025
Historic Leases for Emergent BioSolutions (EBS) over the last 7 years, with Sep 2025 value amounting to $7.2 million.
- Emergent BioSolutions' Leases fell 41.94% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year decrease of 41.94%. This contributed to the annual value of $11.7 million for FY2024, which is 27.78% down from last year.
- As of Q3 2025, Emergent BioSolutions' Leases stood at $7.2 million, which was down 6.49% from $7.7 million recorded in Q2 2025.
- Emergent BioSolutions' 5-year Leases high stood at $29.7 million for Q1 2021, and its period low was $6.6 million during Q1 2025.
- Its 3-year average for Leases is $12.6 million, with a median of $13.7 million in 2024.
- In the last 5 years, Emergent BioSolutions' Leases grew by 21.37% in 2021 and then plummeted by 56.86% in 2025.
- Emergent BioSolutions' Leases (Quarterly) stood at $28.3 million in 2021, then plummeted by 31.45% to $19.4 million in 2022, then fell by 16.49% to $16.2 million in 2023, then decreased by 27.78% to $11.7 million in 2024, then crashed by 41.94% to $7.2 million in 2025.
- Its Leases was $7.2 million in Q3 2025, compared to $7.7 million in Q2 2025 and $6.6 million in Q1 2025.